Sign Out
Active immunisation against diseases caused by Haemophilus influenzae type b
Child: Hiberix or ActHIB Primary immunisation: Infants <6 months 0.5 mL for 3 doses given at intervals of 1-2 months (1st dose may be given as early as 6 weeks of age); infants 6-12 months (previously unvaccinated) 0.5 mL for 2 doses given with an interval of 1 month; children >1-5 years (previously unvaccinated) 0.5 mL as a single dose. Booster dose may be given according to local official guidelines. Liquid PedvaxHIB Primary immunisation: 2-14 months 0.5 mL for 2 doses given at 2 and 4 months of age. If the 2-dose primary immunisation is completed before 12 months of age, a 0.5 mL booster dose must be given at 12-15 months of age (but not earlier than 2 months after the 2nd dose). ≥15 months (previously unvaccinated) 0.5 mL as a single dose. All doses are given via IM inj into the anterolateral thigh or deltoid muscle (older children). Immunisation schedule, approved age and booster dose recommendations may vary among individual products or between countries (refer to specific product or local official guidelines).
